Total Reports
24
FDA CVM filings
Dog /
FDA CVM · 2025 release 24 reports on file
Kuvasz - FDA Adverse Event Profile
Adverse-event records for Kuvasz (Dog) from the FDA Center for Veterinary Medicine.
Data updated June 2026
The record at a glance
Among dog breeds, Kuvasz is #342 by FDA report volume; 8.3% of its 24 reports (2) were death-coded.
- #342
- most-reported dog breed
- 8.3%
- death-coded report share
- 5
- Vomiting - top reaction
- 6.4 yr
- average age at report
Higher volume usually means a more popular breed, not a riskier one, compare against how common the breed is.
Deaths Reported
2
of 24 reports
Death Rate
8.3%
death-coded share
Avg Age at Report
6.4 yr
41.1 kg avg weight
Death-Coded Outcome Share
Kuvasz death-coded reports 8.3%
Cross-breed median
8.3% of 24 kuvasz reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 41.1 kg (90.6 lbs)
Top Reported Reactions
Vomiting 5
Other abnormal test result NOS 5
Anorexia 4
Lack of efficacy (endoparasite) - heartworm 4
Lethargy (see also Central nervous system depression in 'Neurological') 3
Most Referenced Drugs
Fluralaner Chew Tablets 4
Milbemycin Oxime + Spinosad 3
Trilostane 2
Moxidectin 2
Carprofen 2
Outcome Breakdown
Ongoing
9 (42.9%)
Outcome Unknown
5 (23.8%)
Recovered/Normal
3 (14.3%)
Euthanized
2 (9.5%)
Recovered with Sequela
2 (9.5%)
Gender Distribution
Female 12 (50.0%)
Male 12 (50.0%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2010 | 3 | |
| 2012 | 1 | |
| 2013 | 3 | |
| 2014 | 3 | |
| 2015 | 2 | |
| 2016 | 3 | |
| 2017 | 2 | |
| 2019 | 1 | |
| 2020 | 4 | |
| 2023 | 1 | |
| 2024 | 1 | |
Kuvasz Pet Health Insights
Kuvasz accounts for 24 FDA adverse event reports, ranking #342 by volume among dog breeds, with 2 reports (8.3%) coded as a death outcome. Mean age at report: 6.4 years, average weight 41.1 kg (90.6 lbs).
Top reported signs: Vomiting (5), Other abnormal test result NOS (5), Anorexia (4). Most-referenced drug: Fluralaner Chew Tablets (4 reports), followed by Milbemycin Oxime + Spinosad (3) and Trilostane (2).
Outcome coding on 21 status-recorded reports is dominated by Ongoing (42.9%). Annual submissions ranged 2,010-2,024 across 11 years on file.
Dog Breeds With a Similar Report Volume
Frequently Asked Questions
How many FDA adverse event reports involve Kuvasz? ▼
There are 24 adverse event reports involving Kuvasz in the FDA database, with 2 reports involving death (8.3% death rate). Kuvasz ranks #342 by report volume.
What are the most common adverse reactions reported for Kuvasz? ▼
The most commonly reported adverse reactions for Kuvasz are Vomiting (5 reports), Other abnormal test result NOS (5 reports), Anorexia (4 reports), Lack of efficacy (endoparasite) - heartworm (4 reports), Lethargy (see also Central nervous system depression in 'Neurological') (3 reports).
What drugs are most frequently associated with Kuvasz adverse events? ▼
The drugs most frequently referenced in Kuvasz adverse event reports are Fluralaner Chew Tablets (4 reports), Milbemycin Oxime + Spinosad (3 reports), Trilostane (2 reports), Moxidectin (2 reports), Carprofen (2 reports).
What is the average age of Kuvasz in adverse event reports? ▼
The average age of Kuvasz at the time of adverse event reports is 6.4 years, with an average weight of 41.1 kg (90.6 lbs).
Does a high number of adverse event reports mean Kuvasz is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Kuvasz safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how death rate and rankings are computed.
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.